**REGISTERED COMPANY NUMBER: 02755034 (England and Wales) REGISTERED CHARITY NUMBER: 1020193** 

Report of the Trustees and 

## Unaudited Financial Statements 

for the Year Ended 30 September 2022 

## for 

## THE INSTITUTE OF CLASSICAL OSTEOPATHY 

McLean Reid Chartered Accountants 

1 Forstal Road Aylesford Kent ME20 7AU 



THE INSTITUTE OF CLASSICAL OSTEOPATHY 

Contents of the Financial Statements for the Year Ended 30 September 2022 

|||**Page**||
|---|---|---|---|
|**Report of the Trustees**|1|to|2|
|**Independent Examiner's Report**||3||
|**Statement of Financial Activities**||4||
|**Balance Sheet**||5||
|**Notes to the Financial Statements**|6|to|10|





THE INSTITUTE OF CLASSICAL OSTEOPATHY (Registered number: 02755034) 

## Report of the Trustees for the Year Ended 30 September 2022 

The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 30 September 2022. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019). 

## **OBJECTIVES AND ACTIVITIES** 

## **Objectives and aims** 

The objectives of the charity are the promotion and advancement of classical osteopathy. 

## **ACHIEVEMENT AND PERFORMANCE** 

## **Charitable activities** 

During the year the Institute continued to grow in membership, gaining greater and wider interests world-wide. 

## **FINANCIAL REVIEW** 

## **Principal funding sources** 

The main sources of income the charity receives are the donations for providing post graduate courses, conferences, workshops, treatments, etc. and annual subscription fees. 

## **Reserves policy** 

The Institute requires reasonable reserves to fund large gatherings of practitioners to develop and deliver post graduate courses, conferences, workshops, etc. and generally to enable the delivery of educational events which may not always be self-financing. 

## **Going concern** 

The Institute has spent a considerable amount of time during the lockdown caused by Covid19, updating the courses. For the future, a great deal of the modules will take place online with four seminars in person per year in rented locations. The trustees hope this, along with a drive in sales will prevent the Institute's reserves depleting further and consequently the trustees believe the Institute remains a going concern. 

## **STRUCTURE, GOVERNANCE AND MANAGEMENT** 

## **Governing document** 

The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006. 

## **Recruitment and appointment of new trustees** 

In the event of any of the current trustees resigning, the remaining trustees would look to a further appointee who has shown interest and commitment over several years towards the charity. 

## **REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number** 

02755034 (England and Wales) 

## **Registered Charity number** 

1020193 

## **Registered office** 

Timber Top 148 Bridge Road Sarisbury Green Southampton Hampshire SO31 7EJ 

## **Trustees** 

Mr C P Batten Trustee Mr H Lee Trustee Miss B Chaggar Osteopath Mr D Gomez Etayo Osteopath Mr B J Adams Osteopath 

Page 1 



THE INSTIT
TE
OSTEOPATHY
Trustees
30 S lember 2
for the Yéar En
22
REFERE￿E AND ADMINISTrATIVE DETAILS
Ind•pgndgnt Examln•r
A M Reid FCA
MeL*an Reid
Chartered Acrnuntants
1 Forstal Road
Aykslord
Kent
ME20 7AU
Approv&Y by order ofth8 board ol trust￿ on 28 June 2023 and signed on its bghalfby..
Mr
ruste8
Page 2

Inde
endent Examinerfs R
ort to th Tru
THE INSTITUTE OF CLASSICAL OSTEOPATHY
Indopendent exambnorf¥ rgportto tho tru¥teeN of THE INSTITUTE OF CLASSICAL OSTEOPATHY IYh• Company'l
I rèport to the tharty on my examination of the a¢￿Unts of the Cory)any for the year eThYed
30 September 2022.
R••pon8lbllltI￿ and basb of r•port
As Ihe charty's trustees ot th6 Company land 8lso rts diréclors frjr thè ￿rpO￿$ of thmpany lawl you are respons￿)￿ for
the p￿para￿.0rn ofth* a￿Ounts in 8¢corf8ne* with the requirements ofthe Companies Act 2Cth Ilhe 20C6 Acti.
H8wng sab"sf*d mysèlf thAt thè atrAiunts of the Company we not required to be audrted under Part 16 of the 20C6 Act
and are elvib￿ for independent exammats"on, I r8POrt in r8SP8Ct of my •xaminakn'on of your charrty's awounts as ￿T￿le￿
out undèr S8dion 145 of the Ch*be5 Art 2011 ItPE 2011 Ac¥l. In carying out my examination I have folk)￿￿￿ th8
Directions gwen by the Charity CommissKJn U￿er Sectr'on 14SISI Ibl ofthe 2011 Act.
Ind•pgndent •xamln•es 8latom•nt
I haw ¢ompbtsd rny examinati￿. I confim that no mattws have ￿rne to my atten*'on in o)nn8th"on wilh
examination giwry rne ￿uSe to beI￿ve..
acuunts.ng r8cords %%*rè not W in re3pect ofts Company a5 required by Section 386 ofthe 2CpJ6 Art or
the do not aeLord wth those reo)rds'. or
tho accLJunts do Th)t CL¥nply tha accouth.ng wu1￿ments ot Section 396 of the 20C6 Act other than any
requirement that the ￿£Dunts give a true and lair which is not a mattw considarÈd as part of an
independ8nt examination, or
the a¢rA)unts have not been prepared in accordan￿ with the melhods and princ¥)lÉs of thè state￿nt of
Recvmmended Practice for xcounting and reporting by tharitses lappli¢*b to tharibo8 preparirg their a(xounts
in accordanc8 wth tha Finantsal Rapoth"NJ StsrKlard appIl￿ble in ts UK and RepU￿1C of Ireland IFRS 10211.
I havo no c4)nC￿mS and ha￿ come acros5 fK) Otlwr rn¥ttws in conneo*'on wth the exwnination to whKh attention shwkj
ba drabvn in rèwt in order to enabL8 8 proper urKlerstanding of the accounts to be reached.
A PA Rèvj FCA
IlcLean Reid
Chart8r8d Accountants
1 Fo￿tal Ro&J
Aylesford
Kent
ME20 7AU
29 June 2023
Pa98 3

THE INSTITUTE OF CLASSICAL OSTEOPATHY 

## Statement of Financial Activities 

## for the Year Ended 30 September 2022 

|2022<br>Unrestricted<br>fund<br>Notes<br>£<br>**INCOME AND ENDOWMENTS FROM**<br>Donations and legacies<br>-<br>Other trading activities<br>2<br>32,093<br>Investment income<br>3<br>4<br>**Total**<br>32,097<br>**EXPENDITURE ON**<br>Raising funds<br>16,383<br>**Charitable activities**<br>Promotion and advancement of classical<br>osteopathy<br>10,385<br>**Total**<br>26,768<br>**NET INCOME**<br>5,329<br>**RECONCILIATION OF FUNDS**<br>Total funds brought forward<br>23,922<br>**TOTAL FUNDS CARRIED FORWARD**<br>29,251|2021<br>Total<br>funds<br>£<br>50<br>29,719<br>1|
|---|---|
||29,770|
||12,522<br>11,877|
||24,399|
||5,371<br>18,551|
||23,922|



The notes form part of these financial statements 

Page 4 



TITUTE OF CLA
Se
tember 20
2022
Un￿Stric￿￿
nd
2021
Total
nds
FIXED ASSETS
Intangible assets
Tangl)k assets
19
1.033
1,215
1,237
CURRENT ASSETS
Dabtors
Cash at bank
3,837
50.522
4.355
23.552
54,359
27.￿7
CREDITORS
Amounts tslling due wilhin one year
10
Q6,1601
15.2221
NET CURRENT ASSETS
28,199
22.885
TOTAL ASSETS LESS CURRENT UABILITIES
29,251
23.922
NET ASSETS
29.251
23,922
FUNDS
UnreSt￿led fvnds
11
29.251
23,922
TOTAL FUNDS
29.251
23,922
The tharitabb company i% anthkd to ex&mpl*)n frun a￿dr( uTh*r Section 477 01 the Compan￿$ Act 20C6 for ts year
8ndad X) Sept¥mter2022.
The members havo not required the C￿npanY to obtain an audit of ts finanryal statsrnents for the year ended
30 Septsrnber 2022 in awA)rdar￿ wilh Sec*"on 476 oflha CompAn￿S Ad 2Crf)S.
The tru5¢￿ athnovrtedge their ￿POnsI￿1￿ for
lal
ensuring that Ihè charrtable rAynp8ny keeps ac£ounb'ro wrd$ that ¢xmpty wilh Section$ &86 and 387 of Ihe
Cornpanies Act 2CIJ6 and
proparing finane4al statÈft￿nts whith give a true fw'r wew of the ststè ol affairs ol Iha eharrtablÈ company as
at the end of eac* finanaal year anL1 01 rts surplu8 or deficit for eac* financial year in accordan￿ th
raquirgments of SeL*ion5 394 and 395 and which otherwtsa C￿nplY the ￿QUIreMents of the Cornpanies Act
2(th rdating to finanaal statemer¢ts, $0 for 8$ aH)l￿b￿ to the Charitab￿ cx)mpany.
Ibl
These finaTr￿al staternents have pr8p8rnd In ¥Mrdano with the prow5￿ ap￿Icab￿ to charitabb compan
subj'ect lo the small compan￿$ re9im&.
The finawal statements 8kprov&J by Ihe Board of Trust88s and authorisd fcf issue on 28 ju￿ 2023 and were
signwj on rt5 behalf by..
MrDG
Eta
The notes fom part ofth8$8 financ4818taternents
Page 5

THE INSTITUTE OF CLASSICAL OSTEOPATHY 

Notes to the Financial Statements for the Year Ended 30 September 2022 

## **1. ACCOUNTING POLICIES** 

## **Basis of preparing the financial statements** 

The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. 

The trustees consider that there are no material uncertainties related to events or conditions that may cast significant doubt about the ability of the charity to continue as a going concern. 

## **Income** 

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. 

## **Expenditure** 

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources. 

## **Trade marks** 

Amortisation is provided at a rate of 15% on reducing balance in order to write off each asset over its estimated useful life. 

## **Tangible fixed assets** 

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life. 

Plant and machinery - 15% on reducing balance 

## **Taxation** 

The charity is exempt from corporation tax on its charitable activities. 

## **Fund accounting** 

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. 

## **2. OTHER TRADING ACTIVITIES** 

|Subscriptions and meetings<br>Book and video sales<br>Income from courses held<br>Bench & room hire|2022<br>£<br>6,468<br>8,897<br>16,728<br>-<br>32,093|2021<br>£<br>10,921<br>6,601<br>11,897<br>300|
|---|---|---|
|||29,719|



Page 6 

continued... 



THE INSTITUTE OF CLASSICAL OSTEOPATHY 

## Notes to the Financial Statements - continued for the Year Ended 30 September 2022 

## **3. INVESTMENT INCOME** 

|**INVESTMENT INCOME**|||
|---|---|---|
||2022|2021|
||£|£|
|Interest received|4|1|
|**NET INCOME/(EXPENDITURE)**|||
|Net income/(expenditure) is stated after charging/(crediting):|||
||2022|2021|
||£|£|
|Depreciation - owned assets|182|215|
|Patents and licences amortisation|3|5|



## **4. NET INCOME/(EXPENDITURE)** 

## **5. TRUSTEES' REMUNERATION AND BENEFITS** 

During the year, trustees received £7,067 (2021: £4,128) as fees for lecturing to students. **Trustees' expenses** During the year the trustees were re-imbursed £nil (2021: £nil) in expenses. 

## **6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES** 

||Unrestricted|
|---|---|
||fund|
||£|
|**INCOME AND ENDOWMENTS FROM**||
|Donations and legacies|50|
|Other trading activities|29,719|
|Investment income|1|
|**Total**|29,770|
|**EXPENDITURE ON**||
|Raising funds|12,522|
|**Charitable activities**||
|Promotion and advancement of classical||
|osteopathy|11,877|
|**Total**|24,399|
|**NET INCOME**|5,371|
|**RECONCILIATION OF FUNDS**||
|Total funds brought forward|18,551|
|**TOTAL FUNDS CARRIED FORWARD**|23,922|



Page 7 

continued... 



THE INSTITUTE OF CLASSICAL OSTEOPATHY 

## Notes to the Financial Statements - continued for the Year Ended 30 September 2022 

## **7. INTANGIBLE FIXED ASSETS** 

|**COST**<br>At 1 October 2021 and 30 September 2022<br>**AMORTISATION**<br>At 1 October 2021<br>Charge for year<br>At 30 September 2022<br>**NET BOOK VALUE**<br>At 30 September 2022<br>At 30 September 2021<br>**8.**<br>**TANGIBLE FIXED ASSETS**<br>**COST**<br>At 1 October 2021 and 30 September 2022<br>**DEPRECIATION**<br>At 1 October 2021<br>Charge for year<br>At 30 September 2022<br>**NET BOOK VALUE**<br>At 30 September 2022<br>At 30 September 2021<br>**9.**<br>**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**<br>Trade debtors<br>Prepayments|Patents<br>and<br>licences<br>£<br>170<br>148<br>3<br>151<br>19<br>22<br>Plant and<br>machinery<br>£<br>14,469<br>13,254<br>182<br>13,436<br>1,033<br>1,215<br>2022<br>2021<br>£<br>£<br>3,511<br>4,029<br>326<br>326<br>3,837<br>4,355|
|---|---|



Page 8 

continued... 



THE INSTITUTE OF CLASSICAL OSTEOPATHY 

## Notes to the Financial Statements - continued for the Year Ended 30 September 2022 

## **10. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR** 

|**10.**|**CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**||||
|---|---|---|---|---|
||||2022|2021|
||||£|£|
||Trade creditors||-|3,482|
||Deferred income||19,133|-|
||Accrued expenses||7,027|1,740|
||||26,160|5,222|
|**11.**|**MOVEMENT IN FUNDS**||||
||||Net||
|||At|movement|At|
|||1.10.21|in funds|30.9.22|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|23,922|5,329|29,251|
||**TOTAL FUNDS**|23,922|5,329|29,251|
||Net movement in funds, included in the above are as follows:||||
|||Incoming|Resources|Movement|
|||resources|expended|in funds|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|32,097|(26,768)|5,329|
||**TOTAL FUNDS**|32,097|(26,768)|5,329|
||**Comparatives for movement in funds**||||
||||Net||
|||At|movement|At|
|||1.10.20|in funds|30.9.21|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|18,551|5,371|23,922|
||**TOTAL FUNDS**|18,551|5,371|23,922|
||Comparative net movement in funds, included in the above are as follows:||||
|||Incoming|Resources|Movement|
|||resources|expended|in funds|
|||£|£|£|
||**Unrestricted funds**||||
||General fund|29,770|(24,399)|5,371|
||**TOTAL FUNDS**|29,770|(24,399)|5,371|



Page 9 

continued... 



THE INSTITUTE OF CLASSICAL OSTEOPATHY 

## Notes to the Financial Statements - continued for the Year Ended 30 September 2022 

## **11. MOVEMENT IN FUNDS - continued** 

A current year 12 months and prior year 12 months combined position is as follows: 

|**Unrestricted funds**<br>General fund<br>**TOTAL FUNDS**|Net<br>At<br>movement<br>At<br>1.10.20<br>in funds<br>30.9.22<br>£<br>£<br>£<br>18,551<br>10,700<br>29,251<br>18,551<br>10,700<br>29,251|Net<br>At<br>movement<br>At<br>1.10.20<br>in funds<br>30.9.22<br>£<br>£<br>£<br>18,551<br>10,700<br>29,251<br>18,551<br>10,700<br>29,251|
|---|---|---|
|||29,251|



A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows: 

||Incoming|Resources|Movement|
|---|---|---|---|
||resources|expended|in funds|
||£|£|£|
|**Unrestricted funds**||||
|General fund|61,867|(51,167)|10,700|
|**TOTAL FUNDS**|61,867|(51,167)|10,700|



## **12. RELATED PARTY DISCLOSURES** 

Related party transactions are recorded in note 5 to the financial statements. 

Page 10 

